Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

7901 - 7910 of 44782 results found

Remdesivir: treatment of COVID-19 in special populations

Date
Friday, January 05, 2024 - 4:00 AM
Description
Remdesivir (RDV) is the mainstay antiviral therapy for moderate to severe COVID-19. Although remdesivir was the first drug approved for COVID-19, information about its efficacy and safety profile is limited in a significant segment of the population